Animal Healthcare Market - Top Industry players : IDEXX Laboratories, Ceva Sante Animale, Virbac, Phirbo Animal Health, Vetoquinol, Kyoritsu Seiyaku, Norbrook Laboratories, Huvepharma, Dechra Pharmaceuticals, China Animal Husbandry Industry Company, Nippo

Animal healthcare market landscape to be strongly underlined by technology penetration and M&As, global share to surpass USD 36 billion by 2024.

As per the estimates, more than 65% of the U.S. households have pets, a number that is projected to increase exponentially over the coming years. U.S., on this ground, held one of the most prominent positions in the animal healthcare industry in 2017. The region is further claimed to exhibit commendable growth prospects in the coming timeframe, driven by technology breakthroughs in pharmaceuticals and veterinary medicines sectors. As per estimates put forth by Global Market Insights, Inc. North America animal health industry will register a CAGR of 2.2% over 2018-2024.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/735

China is another strong contender in the global animal healthcare industry with the regional growth driven by advancements in veterinary drugs and favorable regional government norms supporting pet keeping. In terms of market expansion opportunities, China is estimated to register a CAGR of 10% over the period of 2018-2024.

Changing animal husbandry trends to dynamically influence animal healthcare market demand

The technological innovations have led to a paradigm shift in the animal husbandry pattern. The animal health companies have also embraced this change which is vividly reflected in their business approach which has traversed a long way from therapeutics, to productivity enhancement, and ultimately to the overall animal healthcare.

India, on account of intensive animal husbandry practices, is slated to witness phenomenal gains in animal healthcare market. As per the estimates, the country accounts for 10% of the overall livestock population and holds the title of the largest producer of fish, chicken, and cattle. The region on account of its rich livestock base is rapidly turning into a profound investment destination for the animal healthcare industry players.

Increasing global population to chart a lucrative roadmap for animal healthcare market

With the rising population, the global meat and dairy consumption rate is set to increase parallelly. It is estimated that in order to feed the world in 2030, the overall animal protein production has to be increased by approximately 30% from what it is at the present. This scenario vividly demonstrates the importance of veterinary drugs and medicines in animal disease prevention and animal health management approach.

Europe, driven by France and U.K., is anticipated to witness a high demand for animal derived pharmaceutical proteins over the coming years, which will indeed make this region a strong avenue for animal healthcare market expansion. As per the estimates, the region held 25% of the overall market share in 2017.

M&As, collaborations, geographic expansion, and R&D to underline animal healthcare industry strategic landscape

Over the years, this industry has strongly been characterized by product innovations, geographical expansion, R&D, and collaborations. Pertaining to this, some of the prominent moves with regards to this fraternity are as listed under:

• In 2015, Eli Lilly and Company acquired Novartis Animal Health for a deal valuation of USD 5.4 billion which reinforced the former’s health division, Elanco’s position in the global animal healthcare market space by enhancing its global commercial presence and R&D capabilities.

• In Jan 2017, the animal healthcare industry registered one of the biggest deals with the collaboration between Sanofi and Boehringer Ingelheim (BI). The deal which was initialized in 2015 was finally closed in Jan this year when Sanofi’s animal health business, Merial was acquired by BI while Sanofi took over the latter’s consumer healthcare business. The deal made Boehringer Ingelheim the world’s second largest animal health company.

• In Jan 2017, Elanco acquired BI Vetmedica, Inc’s U.S. portfolio of feline, rabies, and canine vaccines under a deal value of USD 885 million.

• In July 2017, Zoetis acquired Nexvet, a Tullamore based animal therapeutic company, to develop a pipeline for monoclonal antibody therapies for companion animals.

• Recently, MSD Animal Health, also known as Merck Animal Health, declared its plan to purchase a new manufacturing facility in Austria so as to expand its global vaccine manufacturing capacity.

• Lately, Creso Pharma in collaboration with Virbac, a renowned pharmaceutical animal health company announced to launch hemp-based animal feed products in Switzerland.

Technological innovations to draw the future landscape of animal healthcare market

Traditional strategies might no longer serve the purpose for animal healthcare industry participants over the coming technology-driven years. With the regulatory barriers subsiding gradually, the competition is getting rather intense. In this scenario, it is a must for the animal health companies to revise their business models and approach in sync with the evolving environment. Digital technologies, in this regard, can be a potential platform to enhance the service and product portfolios of the companies. For instance, since 2016, Merial has collaborated with Georgia Institute of Technology’s Center for the Development and Application of Internet of Things Technologies to explore ways in which IoT can help in advancing animal healthcare.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/735

Zoetis is also seeking the help of digital technologies to deliver values to its customers. The firm is participating in a U.K. based project to develop visual imaging means to aid the farmers with enhancing their production efficiency.

With these innovations in pipeline, it is rather undeniable that the animal healthcare industry is all set to witness commendable gains in the ensuing years. In terms of commercialization, the global animal healthcare market is slated to surpass USD 36 billion by 2024 with a CAGR of 4% over 2018-2024.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.